Formulation and optimization of chronomodulated press-coated tablet of carvedilol by Box–Behnken statistical design

References

• Elliott WJ. Timing treatment to the rhythm of disease. A short course in chronotherapeutics. Postgrad Med. 2001;110:119–212, 125–126, 129.
   Google Scholar
• Feuvray D. Circadian rhythms and cardiovascular disease. Heart Metab. 2009;44:3–4.
   Google Scholar
• Satwara RS, Patel PK, Shaikh F. Chronotherapeutical approach: circadian rhythm in human and its role in occurrence and severity of diseases. Int JPharm Tech Res. 2012;4(2):765–777.
   Google Scholar
• Bälan H. Chronotherapy of hypertension: when can be as important as with what. Rom. J Intern Med. 2008;46(4):269–274.
   Google Scholar
• Takeda N, Maemura K. Circadian clock and cardiovascular disease. J Cardiol. 2011;57:259–256.
   Web of Science ®Google Scholar
• Smith DHG. Pharmacology of cardiovascular chronotherapeutic agents. Am JHypertens. 2001;14:296S–301S.
   PubMedGoogle Scholar
• Shigehiro O. Chronotherapeutic strategy: rhythm monitoring manipulation and disruption. Adv Drug Deliv Rev. 2010;62:859–875.
   Web of Science ®Google Scholar
• Smith D, Neutel JM, Weber MA. A new chronotherapeutic oral drug absorption system for verapamil (CODAS-Verapamil) designed for once daily bedtime dosing optimizes blood pressure control in the morning. Am J Hypertens. 2001;14:14–19.
   PubMed Web of Science ®Google Scholar
• White WB, Mehrotra DV, Black HR, Fakouhi TD. Effects of controlled- onset extended-release Verapamil on nocturnal blood pressure (dippers versus nondippers). COER Verapamil Study Group. Am J Cardiol. 1997;80:469–474.
   PubMed Web of Science ®Google Scholar
• Ruffolo RR, Feuerstein GZ, Ohlstein EH. Recent observations with ß-adrenoceptor blockade beneficial effects in hypertension and heart failure. Am J Hypertens. 1998,11(1 Pt 2):9S-14S.
   Google Scholar
• Ding X, Alani AWG, Robinson JR. . Extended release and targeted drug delivery systems. In: Gennaro AR, editor, Remington: The Science and Practice of Industrial Pharmacy. 21st ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2006:993–940.
   Google Scholar
• Collett J, Moreton C. . Modified release peroral dosage forms. In: Aulton ME, editor. Pharmaceutics: The Science of Dosage Form Design. 2nd ed. London, UK: Churchill Livingstone; 2002:289–306.
   Google Scholar
• Hariharan M, Gupta VK. A novel compression-coated tablet dosage form. Pharma Technol. 2001:14–19.
   Google Scholar
• Baichwal A, Sciascia T. From oral drug delivery technology to proprietary product development, In: Oral Drug Delivery: When You Find the Holy Grail. London, UK: Ondrug Delivery Ltd; 2007:7–10.
   Google Scholar
• Sawada T, Kondo H, Nakashima H, Sako K. Time-release compression- coated core tablet containing nifedipine for chronopharmacotherapy. Int JPharm. 2004;280:103–111.
   PubMed Web of Science ®Google Scholar
• Nayak UG. Chronotherapeutic drug delivery for early morning surge in blood pressure: a programmable delivery system. J Control Release. 2009;136:125–131.
   PubMed Web of Science ®Google Scholar
• Prajapati BG, Patel GN, Solanki HN. Formulation and statistical optimization of time controlled pulsatile release propranolol hydrochloride compression coated tablet. Eur JSci Tech. 2010;4:10–19.
   Google Scholar
• Gupta V Hariharan M, Wheatly TA, Price JC. Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors. Eur J Pharm Biopharm. 2001;51:241–248.
   PubMed Web of Science ®Google Scholar
• Wells JI, Aulton ME. . Pharmaceutical preformulation. In: Aulton ME, editor. Pharmaceutics – The Design and Manufacture of Medicines. 3rd ed. Philadelphia, PA: Elsevier, Churchill Livingstone; 2007:337–360.
   Google Scholar
• Ragonese R, Macka M, Hughes J, Petocz P. The use of Box-Behnken experimental design in the optimisation and robustness testing of a capillary electrophoresis method for the analysis of ethambutol hydrochloride in a pharmaceutical formulation. J Pharm Biomed Anal. 2002;27(6):995–1007.
   PubMed Web of Science ®Google Scholar
• Ferreira SLC, Bruns RE, Ferreira HS, et al. Box-Behnken design: an alternative for the optimization of analytical methods. Anal Chim Acta. 2007;597:179–186.
   PubMed Web of Science ®Google Scholar
• Myers RH, Montgomery DC. Response Surface Methodology: Process and product optimization using designed experiments. 2nd ed. New York, NY: Wiley; 2002.
   Google Scholar
• Indian Pharmacopeia 2010. New Delhi, India: Ministry Of Health and Family Welfare, Government of India, The Indian Pharmacopeia Commission Ghaziabad; 2010.
   Google Scholar
• Fell JT, Newton JM. Determination of tablet strength by the diametrical compression test. J Pharm Sci. 1970;59:688–691.
   PubMed Web of Science ®Google Scholar
• Yeole PG, Galgatte C, Babla CI, Nakhat PD. Design and evaluation of xanthan gum-based sustained release matrix tablets of Diclofenac sodium. Indian J Pharm Sci. 2006;68(2):185–189.
   Google Scholar
• Sweet Man SC. Martindale: The Complete Drug Reference. 35th ed. London, UK: Pharmaceutical Press, Publications Department of the Royal Pharmaceutical Society of Great Britain; 2005:1114.
   Google Scholar
• Lehto P, Kortejärvi H, Liimatainen A, et al. Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs. Eur J Pharm Biopharm. 2011;78:531–538.
   PubMed Web of Science ®Google Scholar
• Alastair J, Coupe 1, Stanley S, et al. The effect of sleep on the gastrointestinal transit of pharmaceutical dosage forms. Int J Pharma. 1992;78:69–76.
   Web of Science ®Google Scholar
• Kumar D, Wingate DL, Ruckebusch Y. Circadian variation in the propagation velocity of the migrating myoelectric complex. Gastroenterology. 1986;91:926–930.
   PubMed Web of Science ®Google Scholar
• Kumar D, Idzikowski C, Wingate DL, et al. Relationship between enteric migrating motor complex and the sleep cycle. Am J Physiol. 1990;259(6 Pt 1):G983–G990.
   Google Scholar
• Singh B, Ahuja N. . Response surface optimization of drug delivery system. In: Jain NK, editor. Progress in Controlled and Novel Drug Delivery Systems. 1st ed. New Delhi, India: CBS Publishers and Distributors; 2004:470–509.
   Google Scholar
• Doombos A, Haan P. Optimization technique in formulation and processing. In: Swadbrick J, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology. New York, NY: Marcel Dekker Inc; 1995:77–160.
   Google Scholar
• Kshirsagar SJ, Patil SV, Bhalekar MR. Statistical optimization of floating pulsatile drug delivery system for chronotherapy of hypertension. Int Pharm Invest. 2011;1:207–213.
   Google Scholar
• Furlanetto S, Cirri M, Maestrelli F, Corti G, Mura P. Study of formulation variables influencing the drug release rate from matrix tablets by experimental design. Euro J Pharm Biopharm. 2006;62:77–84.
   PubMed Web of Science ®Google Scholar
• Patil S, Pund S, Joshi A, et al. Chronomodulated press-coated pulsatile therapeutic system for aceclofenac: optimization of factors influencing drug release and lag time. Chronophys Ther. 2011;1:1–10.
   Google Scholar